Status:
COMPLETED
Fish Gelatin Supplement and Omega-3 Supplement in Obese or Overweight Subjects With Insulin Resistance
Lead Sponsor:
Laval University
Collaborating Sponsors:
Advance Foods and Materials Network
Institut des Nutraceutiques et Aliments fonctionnels, Quebec (Clinical nutrition facilities)
Conditions:
Insulin Resistance
Type 2 Diabetes
Eligibility:
All Genders
40-70 years
Phase:
PHASE2
Brief Summary
The present study was conducted to test whether a fish gelatin supplement combined with an omega-3 polyunsaturated fatty acid supplement can exert beneficial and sex-specific effects on insulin sensit...
Detailed Description
An important number of recent epidemiological studies have demonstrated the beneficial effects of marine omega-3 polyunsaturated fatty acids (n-3 PUFA) on cardiovascular disease risk factors such as r...
Eligibility Criteria
Inclusion
- overweight or obese (body mass index \[BMI\] between 25 and 40kg/m2)
- fasting plasma glucose below 7.0mmol/L and 2-h plasma glucose below 11.1mmol/L
- fasting plasma insulin above 90pmol/L
Exclusion
- Diabetes, chronic, metabolic or acute disease
- Major surgery within the last 3 months
- Significant weight loss (±10%) within the last 6 months
- Any medication-taking known to affect lipid of glucose metabolism
- Allergy, intolerance or dislike of fish
- Smokers
Key Trial Info
Start Date :
November 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT01215903
Start Date
November 1 2007
End Date
May 1 2009
Last Update
October 25 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laval University
Québec, Quebec, Canada, G1V 0A6